XML 91 R88.htm IDEA: XBRL DOCUMENT
v3.20.1

Business Combinations - Cost, FV of Assets, Goodwill and Other (Details) € in Thousands, $ in Thousands |  |  |  | 1 Months Ended | 8 Months Ended | 12 Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Apr. 30, 2019 EUR (€) | Jan. 26, 2018 USD ($) | Jan. 12, 2018 EUR (€) | Jun. 30, 2018 EUR (€) m² employee Center item l | Dec. 31, 2019 EUR (€) | Dec. 31, 2019 EUR (€) | Dec. 31, 2018 EUR (€) | Dec. 31, 2017 EUR (€) l | Dec. 31, 2016 EUR (€) | May 31, 2019 EUR (€) | Apr. 30, 2019 USD ($) | Apr. 30, 2019 EUR (€) | Dec. 31, 2018 USD ($) Center | Dec. 31, 2018 EUR (€) Center | Dec. 28, 2018 USD ($) | Dec. 01, 2018 EUR (€) | Aug. 31, 2018 EUR (€) | Aug. 01, 2018 USD ($) Center | Aug. 01, 2018 EUR (€) Center | Mar. 19, 2018 EUR (€) | Jan. 26, 2018 EUR (€) | Jul. 25, 2017 EUR (€) | Jun. 01, 2017 | Feb. 28, 2017 USD ($) | Feb. 28, 2017 EUR (€) | Jan. 31, 2017 USD ($) | Jan. 31, 2017 EUR (€) | Dec. 31, 2016 USD ($) | Dec. 27, 2016 USD ($) Center | Dec. 14, 2016 USD ($) | May 11, 2016 USD ($) Center item | May 11, 2016 EUR (€) Center item | Sep. 30, 2014 EUR (€)
Biotest Us Corporation and Haema AG |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Consideration for sale of subsidiary | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 538,014 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Plasma Donor Centers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payment in cash |  |  |  |  |  |  |  |  |  | € 20,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of net assets acquired |  |  |  |  |  |  |  |  |  | 1,620 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired) |  |  |  |  |  |  |  |  |  | 18,880 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total business combination cost |  |  |  |  |  |  |  |  |  | 20,500 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment recognised as of acquisition date |  |  |  |  |  |  |  |  |  | € 1,396 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interstated Blood Bank, Inc. Group |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payment in cash |  |  |  |  |  |  |  |  |  |  | $ 100,000 | € 88,984 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 100,000 | € 88,215 |
Purchase price for the remaining stakes | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 |  |
Fair value of the previous investment in the company |  |  |  |  |  |  |  |  |  |  | 105,779 | 94,126 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of the call option |  |  |  |  |  |  |  |  |  |  | 10,000 | 8,898 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of net assets acquired |  |  |  |  |  |  |  |  |  |  | 21,744 | 19,345 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired) |  |  |  |  |  |  |  |  |  |  | 194,035 | 172,663 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total business combination cost |  |  |  |  |  |  |  |  |  |  | 100,000 | 88,984 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment recognised as of acquisition date |  |  |  |  |  |  |  |  |  |  | $ 26,661 | € 23,724 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Agreed payment amount for call option |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 10,000 | € 9,007 |
Number of blood donation centers | Center |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 9 | 9 |
Number of plasma collection centers | Center |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 26 | 26 |
Number of laboratories | item |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 1 |
Increase (decrease) in combined revenue had the acquisition taken place on January 1 |  |  |  |  |  | € 10,146 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Increase (decrease) in combined profit had the acquisition taken place on January 1 |  |  |  |  |  | (1,436) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue of acquiree since acquisition date |  |  |  |  | € 13,364 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Profit of acquiree since acquisition date |  |  |  |  | € 280 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Variation between the fair value of the previous investment and the book value | € 4,521 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interstate Blood Bank, Inc |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest acquired (as a percent) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 49.19% | 49.19% |
Bio Blood Components Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest acquired (as a percent) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48.97% | 48.97% |
Plasma Biological Services, LLC. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest acquired (as a percent) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48.90% | 48.90% |
Biotest Acquisition |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of net assets acquired |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 133,761 | € 114,463 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 152,693 | 130,663 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total business combination cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 286,454 | 245,126 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment recognised as of acquisition date |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 25,931 | € 22,190 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of plasma collection centers | Center |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 24 | 24 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest acquired (as a percent) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100.00% | 100.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |
Plasma collected in preceding financial year (in litres) | l |  |  |  |  |  |  |  | 850,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Increase (decrease) in combined revenue had the acquisition taken place on January 1 |  |  |  |  |  |  | € 90,216 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Increase (decrease) in combined profit had the acquisition taken place on January 1 |  |  |  |  |  |  | 5,592 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue of acquiree since acquisition date |  |  |  |  |  |  | 73,747 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Profit of acquiree since acquisition date |  |  |  |  |  |  | 7,473 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Kedplasma Centers |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payment in cash |  |  |  |  |  |  |  |  |  |  |  |  | $ 50,163 | € 42,780 |  | € 21,841 | € 20,939 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of net assets acquired |  |  |  |  |  |  |  |  |  |  |  |  | 5,787 | 5,042 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired) |  |  |  |  |  |  |  |  |  |  |  |  | 44,376 | 37,738 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total business combination cost |  |  |  |  |  |  |  |  |  |  |  |  | $ 50,163 | 42,780 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment recognised as of acquisition date |  |  |  |  |  |  |  |  |  |  |  |  |  | € 4,942 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of plasma centers owned | Center |  |  |  |  |  |  |  |  |  |  |  |  | 6 | 6 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Haema, AG |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of net assets acquired |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 49,057 |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 171,134 |  |  |  |  |  |  |  |  |  |  |  |  |
Total business combination cost |  |  |  | € 220,191 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 220,191 |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment recognised as of acquisition date |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 25,407 |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest acquired (as a percent) |  |  |  | 100.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of plasma centers owned | Center |  |  |  | 35 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of plasma collection centers under construction | Center |  |  |  | 3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Area of headquarters (in square metre) | m² |  |  |  | 24,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total number of employees | employee |  |  |  | 1,100 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Plasma collected in preceding financial year (in litres) | l |  |  |  | 800,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of plasma donations collected | item |  |  |  | 1,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Increase (decrease) in combined revenue had the acquisition taken place on January 1 |  |  |  |  |  |  | 39,517 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue of acquiree since acquisition date |  |  |  |  |  |  | 46,758 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Profit of acquiree since acquisition date |  |  |  |  |  |  | € 53 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goetech, LLC. ("MedKeeper") |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of net assets acquired |  | $ 17,207 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 14,104 |  |  |  |  |  |  |  |  |  |  |  |
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired) |  | 67,492 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 55,321 |  |  |  |  |  |  |  |  |  |  |  |
First repurchase of non-controlling interests |  | 14,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 11,475 |  |  |  |  |  |  |  |  |  |  |  |
Second repurchase of non-controlling interests (discounted amount) |  | 18,241 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 14,952 |  |  |  |  |  |  |  |  |  |  |  |
Purchase of remaining non-controlling interests |  | 52,458 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 42,998 |  |  |  |  |  |  |  |  |  |  |  |
Total business combination cost |  | 84,699 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 69,425 |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment recognised as of acquisition date |  | 82 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 67 |  |  |  |  |  |  |  |  |  |  |  |
Share capital increase | $ |  | $ 98,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest acquired (as a percent) |  | 51.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 51.00% |  |  |  |  |  |  |  |  |  |  |  |
Ownership in subsidiary (as a percent) |  | 51.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Repurchase of own shares from noncontrolling shareholder in 2 business days | $ |  | $ 14,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Repurchase of own shares from noncontrolling shareholder in two years | $ |  | $ 20,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option to purchase remaining voting rights, term (in years) |  | 3 years |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Revenue of acquiree since acquisition date |  |  |  |  |  | 9,210 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Profit of acquiree since acquisition date |  |  |  |  |  | € 1,778 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aigues Minerals de Vilajuiga S. A. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total business combination cost |  |  | € 550 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership interest acquired (as a percent) |  |  | 50.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50.00% |  |  |  |  |  |  |  |  |  |
Ownership in subsidiary (as a percent) |  |  | 100.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Hologic acquisition |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payment in cash |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,865,000 | € 1,734,077 |  |  | $ 1,865,000 |  |  |
Fair value of net assets acquired |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 332,923 | 309,551 |  |  |  |  |  |
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,577,134 | 1,466,420 |  |  |  |  |  |
Result of the cancellation of the existing contract |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 45,057 | 41,894 |  |  |  |  |  |
Total business combination cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,910,057 | 1,775,971 |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment recognised as of acquisition date |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 26,424 | € 24,569 |  |  |  |  |  |
Expenses incurred for acquisition |  |  |  |  |  |  |  | € 13,000 | € 5,100 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Kiro Grifols S.L (formerly Kiro Robotics S.L) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share capital increase |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 21,000
Ownership interest acquired (as a percent) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 40.00% |  |  |  |  |  |  |  |  |  |  | 50.00%
Additional ownership interest acquired, consideration transferred |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 12,800 |  |  |  |  |  |  |  |  |  |  |
Ownership in subsidiary (as a percent) |  |  |  |  |  | 90.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Kiro Grifols S.L (formerly Kiro Robotics S.L) | Socios Fundadores Kiro, S.L. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Ownership in subsidiary held by noncontrolling interests (as a percent) |  |  |  |  |  | 10.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Kedplamsa acquisition |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Details of the aggregate business combination cost, fair value or net assets acquired and goodwill: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Payment in cash |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 47,083 | € 44,238 |  |  |  | $ 47,000 |  |  |  |
Fair value of net assets acquired |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,403 | 4,137 |  |  |  |  |  |  |  |
Goodwill (excess of the cost of the business combination over the fair value of net assets acquired) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 42,680 | 40,101 |  |  |  |  |  |  |  |
Total business combination cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 47,083 | 44,238 |  |  |  |  |  |  |  |
Other disclosures: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Property, plant and equipment recognised as of acquisition date |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 3,698 |  |  |  |  |  |  |  |
Number of Plasma Donor Centers acquired | Center |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6 |  |  |  |
Advance paid for acquisition | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 15,000 |  |  |  |  |

X
- Definition The acquisition-date fair value of call option entered into by the company in a business combination transaction. + References No definition available. + Details
Name: | grfs_AcquisitionDateFairValueOfCallOptionConsideration
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The fair value, at the acquisition date, of the consideration transferred in a business combination related to the first repurchase of non-controlling interests. + References No definition available. + Details
Name: | grfs_AcquisitionDateFairValueOfConsiderationTransferredFirstRepurchaseOfNonControllingInterest
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The fair value at acquisition date, of the consideration transferred in a business combination related to the repurchase of the remaining non-controlling interests. + References No definition available. + Details
Name: | grfs_AcquisitionDateFairValueOfConsiderationTransferredPurchaseOfRemainingNonControllingInterest
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The fair value, at acquisition date, of the consideration transferred in a business combination related to the second repurchase of non-controlling interests (discounted amount). + References No definition available. + Details
Name: | grfs_AcquisitionDateFairValueOfConsiderationTransferredSecondRepurchaseOfNonControllingInterest
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of acquisition-related costs. + References No definition available. + Details
Name: | grfs_AcquisitionRelatedCosts
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The measurement area of the headquarters. + References No definition available. + Details
Name: | grfs_AreaOfHeadquarters
Namespace Prefix: | grfs_
Data Type: | num:areaItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of consideration received on sale of subsidiaries. + References No definition available. + Details
Name: | grfs_ConsiderationOnSaleOfSubsidiary
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of cancellation cost of existing contract due to business combination. + References No definition available. + Details
Name: | grfs_CostOfCancellationOfExistingContractDueToBusinessCombination
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Disclosure Of Business Combination Other Disclosures [Abstract] + References No definition available. + Details
Name: | grfs_DisclosureOfBusinessCombinationOtherDisclosuresAbstract
Namespace Prefix: | grfs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase (decrease) in the profit (loss) of the combined entity as though the acquisition date for all business combinations that occurred during the year had been as of the beginning of the annual reporting period. + References No definition available. + Details
Name: | grfs_IncreaseDecreaseInProfitLossOfCombinedEntity
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of increase (decrease) in the revenue of the combined entity as though the acquisition date for all business combinations that occurred during the year had been as of the beginning of the annual reporting period. + References No definition available. + Details
Name: | grfs_IncreaseDecreaseInRevenueOfCombinedEntity
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The price paid by the entity for an option to purchase the remaining ownership interests of associates in which it holds a proportionate ownership interest. + References No definition available. + Details
Name: | grfs_InterestsInAssociatesCallOptionPurchaseOfRemainingOwnershipInterestsOptionPricePaid
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The purchase price to be paid by the entity under an option to purchase the remaining ownership interests of associates in which it holds a proportionate ownership interest. + References No definition available. + Details
Name: | grfs_InterestsInAssociatesCallOptionPurchaseOfRemainingOwnershipInterestsPurchasePrice
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Represents the number of blood donation centers. + References No definition available. + Details
Name: | grfs_NumberOfBloodDonationCenters
Namespace Prefix: | grfs_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of business units acquired. + References No definition available. + Details
Name: | grfs_NumberOfBusinessUnitsAcquired
Namespace Prefix: | grfs_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of plasma donations collected. + References No definition available. + Details
Name: | grfs_NumberOfDonations
Namespace Prefix: | grfs_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the number of laboratories. + References No definition available. + Details
Name: | grfs_NumberOfLaboratories
Namespace Prefix: | grfs_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of plasma centers owned. + References No definition available. + Details
Name: | grfs_NumberOfPlasmaCentersOwned
Namespace Prefix: | grfs_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the number of plasma collection centers. + References No definition available. + Details
Name: | grfs_NumberOfPlasmaCollectionCenters
Namespace Prefix: | grfs_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of plasma collection centers acquired under construction. + References No definition available. + Details
Name: | grfs_NumberOfPlasmaCollectionCentersUnderConstruction
Namespace Prefix: | grfs_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Term of option to purchase remaining voting rights, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | grfs_OptionToPurchaseRemainingVotingRightsTerm
Namespace Prefix: | grfs_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The consideration transferred as a result of additional ownership interest acquired. + References No definition available. + Details
Name: | grfs_OwnershipInterestAcquiredConsiderationTransferred
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash outflow for payment of advance for business acquisition. + References No definition available. + Details
Name: | grfs_PaymentOfAdvanceForBusinessAcquisition
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Plasma collected in preceding financial year. + References No definition available. + Details
Name: | grfs_PlasmaCollectedInPrecedingYear
Namespace Prefix: | grfs_
Data Type: | num:volumeItemType
Balance Type: | na
Period Type: | duration

X
- Definition The repurchase of own shares from non-controlling interest within 2 business days as per acquisition agreement. + References No definition available. + Details
Name: | grfs_RepurchaseOfOwnSharesFromNonControllingInterestInTwoBusinessDays
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The repurchase of own shares from non-controlling interest within two years as per acquisition agreement. + References No definition available. + Details
Name: | grfs_RepurchaseOfOwnSharesFromNonControllingInterestInTwoYears
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The value of share capital increase in a company. + References No definition available. + Details
Name: | grfs_ShareCapitalIncreaseValue
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount by which the fair value of previous investment varies with the book value of investment. + References No definition available. + Details
Name: | grfs_VariationBetweenFairValueOfPreviousInvestmentAndBookValue
Namespace Prefix: | grfs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The acquisition-date fair value of equity interest in the acquiree held by the acquirer immediately before the acquisition date in a business combination achieved in stages. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -Subparagraph p -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64_p_i&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -Subparagraph f -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferredAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -Subparagraph f -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_CashTransferred
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64&doctype=Appendix&subtype=B -URIDate 2019-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph IE72 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_IE72&doctype=Illustrative%20Examples -URIDate 2019-03-27 + Details
Name: | ifrs-full_GoodwillRecognisedAsOfAcquisitionDate
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -Subparagraph i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B -URIDate 2019-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph IE72 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_IE72&doctype=Illustrative%20Examples -URIDate 2019-03-27 + Details
Name: | ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The number of personnel employed by the entity at a date. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2019-01-01 -Paragraph 112 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2019-en-r&anchor=para_112_c&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_NumberOfEmployees
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_PercentageOfVotingEquityInterestsAcquired
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -Subparagraph q -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_ProfitLossOfAcquiree
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -Subparagraph i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B -URIDate 2019-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph IE72 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_IE72&doctype=Illustrative%20Examples -URIDate 2019-03-27 + Details
Name: | ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2019-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2019-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2019-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2019-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2019-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2019-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2019-01-01 -Paragraph 19B -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2019-en-r&anchor=para_19B_c&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestInSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2019-01-01 -Paragraph 12 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2019-en-r&anchor=para_12_c&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
Namespace Prefix: | ifrs-full_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of revenue of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. [Refer: Revenue] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2019-01-01 -Paragraph B64 -Subparagraph q -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2019-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_RevenueOfAcquiree
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ifrs-full_SignificantInvestmentsInSubsidiariesAxis=grfs_BiotestUsCorporationAndHaemaAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_PlasmaDonorCentersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_InterstatedBloodBankInc.GroupMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_InterstateBloodBankIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_BioBloodComponentsIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_PlasmaBiologicalServicesLimitedLiabilityCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_BiotestAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_KedplasmaCentersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_HaemaAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_GoetechLlc.AcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_AiguesMineralsDeVilajuigaS.A.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_HologicAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_KiroGrifolsS.lMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=grfs_SociosFundadoresKiroS.l.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=grfs_KedplasmaAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |